Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.625 -5.32% 11.125 11.00 11.25 11.75 11.125 11.75 1,876,784 14:48:40
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 23

Futura Medical Share Discussion Threads

Showing 16826 to 16850 of 18675 messages
Chat Pages: Latest  675  674  673  672  671  670  669  668  667  666  665  664  Older
DateSubjectAuthorDiscuss
09/6/2019
08:32
Great article kd, many thanks.
rrr
09/6/2019
06:45
guardian webiste- The race to replace Viagra https://www.theguardian.com/science/2019/jun/09/race-to-replace-viagra-patents-erectile-dysfunction-drug-medical-research-cialis-eroxon
keifer derrin
07/6/2019
12:29
Im still in hear quite heavily and comfortable with it. Trying not to look too often as it will be a bit of a slow burn until later in the year with fee mm shenanagans in between.
ragnarr
07/6/2019
12:20
Buyers back in !!
dickiebird2
07/6/2019
11:20
certainly 'bottom testing' !
mikethebike4
06/6/2019
15:20
Testing the bottom of the up trend channel, if it holds, it should do well from here.
ny boy
06/6/2019
14:25
I expect some dip buying over the next week or so, before a break to new highs
ny boy
06/6/2019
14:11
Everyone sold out ? I guess no long term investors left then lol! (MSYS) is the next big thing imo but dyor!
ny boy
29/5/2019
10:24
Anyone joining the MAIS shareholder action group?
kemche
29/5/2019
09:52
LO selling again Good luck ... placing coming
ayesha4
24/5/2019
11:11
You are not wrong there Global Erectile Dysfunction Drugs Market Will Reach USD 7.10 Billion by 2024: Zion Market Research According to the report, global erectile dysfunction drugs market was valued at approximately USD 4.82 billion in 2017 and is expected to generate revenue of around USD 7.10 billion by end of 2024, growing at a CAGR of around 5.70% between 2018 and 2024.
ragnarr
24/5/2019
09:51
Not surprising when you consider the upside.
j777j
24/5/2019
09:40
some quite hefty buys today - 50k, 100k, 250k - somebody must be taking an interest
mikethebike4
23/5/2019
15:10
Ahead of the rerating one hopes.
j777j
23/5/2019
14:59
That was definately a tree shake!
xippy
23/5/2019
14:04
Buy note out soon?
j777j
23/5/2019
11:41
FrOm the redent preliminary results. "Cash Balance Cash balance at the end of 2018 was £9.16 million (2017: £8.36 million). Cash burn during the year was £5.63 million (2017: £5.02 million) primarily in relation to MED2005 research and development activities. Net funding of £5.48 million was raised in the year, resulting in a net cash inflow of £0.80 million. Futura is fully funded to deliver the top line data from the first Phase 3 study and will manage its funding strategy appropriately to what is expected to be a material inflection point for the Company." The MED2005 clinical trial Protocol states Estimated Primary Completion Date : October 7, 2019 This isn,t the completion of the whole study that will be later in 2020 but at some point after October there will be update data available to know where its going.Reading all the data to date I think it is safe to say that there is a certain confidence in this Trial. So if there were to be another placing (which is perfectly feasable) it wont be until that upodate is available and the share price is far higher. IMO
ragnarr
23/5/2019
11:16
New broker -its good news as they can offer much more than previous one and will want toshow how they can do this and get the share price back to a sensible level. In my view some good news is due and they want the new broker to deal with this. Could well be approval for use of the pain products which is due anytime now. Rhat would give abig lift to the share price.
loobrush
23/5/2019
09:35
If only sensible people held shares.This is positive news they are a far bigger company than Singer.It has nothing to do with a placing.FUM are completely funded for the foreseeable future.The MM's saw you coming and have mugged you yet again.
martinelwick
23/5/2019
08:43
Typical that any placing could have been done in mid 20s. So why leave till now, when so many institutions have been burnt in this stock, how areLiberum going to get it away except at big discount?Wonder how LO will play it.Every time step forward, one can guarantee step back.
wantage
23/5/2019
07:33
Nice little buying op - thanks
ragnarr
23/5/2019
07:20
As I have said on previous occasions the risk here is barder, he is out of his depth and will probably be persuaded to raise funds
slicethepie
23/5/2019
06:51
10 p i reckon
ayesha4
23/5/2019
06:31
pjj71 exactly what I thought (captial raise) here's their website hxxp://www.liberum.com/ are working with some big companies....
keifer derrin
23/5/2019
06:17
Hopefully comes with decent broker note explaining potential.
j777j
Chat Pages: Latest  675  674  673  672  671  670  669  668  667  666  665  664  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200119 07:10:13